Antibody Drug Conjugates Market Growth Drivers, Challenges and Forecast to 2031
Advancements in targeted oncology therapies are transforming the treatment landscape for a wide range of cancers. Improved biologic engineering, innovative linker technologies, and increasing regulatory support are accelerating the commercialization of next generation therapeutic solutions. The Antibody Drug Conjugates Market is projected to grow from US$ 8,105.65 million in 2023 to US$...
0 Comments 0 Shares 145 Views 0 Reviews